Mifepri­s­tone on tri­al: What to know about the Supreme Court oral argu­ments

The Supreme Court is con­sid­er­ing a law­suit meant to reverse the Food and Drug Administration’s approval of the abor­tion pill mifepri­s­tone. The case has major ram­i­fi­ca­tions for abor­tion access, giv­en that a major­i­ty of abor­tions are now per­formed via med­ica­tion. It also could reshape the 2024 elec­tions, in which abor­tion is expect­ed to be a sig­nif­i­cant con­sid­er­a­tion for vot­ers. The Wash­ing­ton Exam­in­er is fea­tur­ing a series of arti­cles pro­vid­ing an in-depth look at the case and its impli­ca­tions. Th …